Clinical Trial Update: Phase 3 Study to Evaluate the Efficacy and Safety of Droxidopa on Orthostatic Hypotension Treatment in Hemodialysis Patients [Phase 3]

View source ↗

Summary

A Phase 3 study evaluating droxidopa for orthostatic hypotension in hemodialysis patients was terminated.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Orthostatic Hypotension

Drugs mentioned

• Droxidopa (Droxidopa)

Snippet

Sponsor: TSH Biopharm Corporation Limited | Conditions: Orthostatic Hypotension | Phase 3 | Status: TERMINATED